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Introduction
Verrucae vulgaris are caused by human papilloma virus 
(HPV) strains 1, 2, 4, 7, 57 [1] and have a prevalence of 
approximately 10% [2]. Although verrucae are often 
self-limited, palmoplantar warts can be particularly 
recalcitrant to multiple treatment modalities and 
symptomatic when located periungually or on the 
palmar and plantar surfaces. We report a 33-year-old 
man with recalcitrant plantar warts with a significant 
response to a combination of oral acitretin and 40% 
urea cream.
Case Synopsis
We report a 33-year-old man with a 3-4-year history of 
recalcitrant, diffuse verruca vulgaris over the bilateral 
plantar feet and toes who required treatment with 
daily oral acitretin 25 mg and twice daily urea cream 
40% for symptomatic and clinical control (Figure 1). 
After 1 month of this new treatment regimen, his 
multiple, thick, verrucous papules were significantly 
thinner (Figure 2). At the end of 4 months he 
experienced near complete clinical clearance. 
Additionally pain with ambulation that had been 
present for years had completely resolved.
The patient had previously failed cryotherapy, 
cimetidine, and ‘formaldehyde with scraping.’ He 
was also unable to tolerate intralesional candidin 
injections owing to pain. He had no history of 
Abstract
Plantar warts caused by human papilloma virus (HPV) 
may be challenging to treat when conventional 
modalities fail. We report a case of severely recalcitrant 
plantar warts, successfully treated with oral acitretin 
and topical 40% urea cream.
Figure 2. Post-treatment picture showing markedly reduced size 
of the warts.
Figure 1. Pre-treatment showing presence of warts over soles
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constitutional symptoms, immunosuppression, risk 
for human immunodeficiency virus, or family history 
of warts or immunodeficiencies,
Owing to severe pain with walking, systemic 
treatment with daily oral acitretin was initiated in 
January 2016 in combination with urea cream 40% 
twice daily. Baseline routine laboratory evaluations 
including liver function tests and lipid profile 
were notable for mildly elevated triglycerides and 
cholesterol. The patient’s hypertension, was being 
monitored and treated by the patient’s primary 
care physician. The only side effect of acitretin and 
urea cream was dryness, controlled with liberal 
moisturizing. Liver function tests remained within 
normal limits and lipid profile was unchanged during 
the treatment period.
Case Discussion
Treatment of viral warts can be challenging in the 
face of recalcitrant lesions. Plantar warts can be 
associated with significant pain and may therefore 
interfere with activities of daily living.
Previous case reports in immunocompetent patients 
have demonstrated improvements in recalcitrant 
warts with acitretin. Choi et al. reported significant 
improvement after 2 months of 1 mg/kg/day 
acitretin in a 25-year old man with multiple warts on 
the bilateral hands [3]. Although after discontinuing 
acitretin the warts recurred, improvement was 
again seen after restarting treatment with acitretin 
[3]. Another report describes successful clearance 
of long-standing periungual warts in a 46-year-old 
woman after with a three-month course of acitretin, 
25 mg daily, followed by every other day dosing. 
Clinical remission was maintained 6 months after 
discontinuation of treatment [4].
Recalcitrant warts on the scalp and beard areas, 
resistant to conventional treatments have been 
successfully treated with acitretin 0.5mg/kg/day for 3 
months in combination with cryotherapy during the 
first month, with improvement observed as early as 
four weeks. Clearance was maintained 5 months after 
stopping acitretin [5]. In another report a 20-year old 
man with warts on face, palm, and left extremity 
present for a duration of 6-years experienced 
complete clearance of his lesions with acitretin 0.5 
mg/kg/day continued for 3 months. The patient was 
followed-up for 6 months after treatment with no 
recurrence of lesions [6]. Another report documented 
significant regression in wart size at 1 month and 
complete flattening after 3 months in a 32-year-old 
man with multiple warts on his hands, fingers, and 
periungual area after treatment with acitretin 0.3 
mg/kg/day. There was no recurrence 3 months after 
stopping treatment [1].
Oral acitretin has been also been successful in 
treating giant condyloma acuminatum, giant 
warts in an immunocompromised patient, and 
epidermodysplasia verruciformis, an autosomal 
recessive disorder marked by widespread HPV 
infection [12-15].
The side effect profiles of acitretin among these cases 
are mild and include xerosis and chelitis, without 
clinically significant laboratory abnormalities or 
other side effects. Selection of appropriate patients 
for treatment with acitretin is also important. In 
particular, one should avoid this medication in 
women of childbearing potential and in those with 
other medical co-morbidities such as mood disorders 
and alcoholism.
The efficacy of retinoid in wart therapy is believed to 
be related to their influence on the regulation of cell 
growth and differentiation with resulting inhibition 
of viral replication and assembly within infected 
cells [3, 9]. An inverse relationship between retinoid 
concentration and level of HPV DNA supports the 
role of retinoids in inhibition of viral replication [7]. 
Retinoids are not only potent immunomodulators 
[8], but also have apoptotic activity, which likely 
contributes to wart clearance [10]. Whereas topical 
vitamin A (i.e. tretinoin) also can be effective for warts 
[11], oral therapy was preferred in our patient owing 
to significant wart thickness.
Conclusion
Plantar warts may be challenging to treat with 
traditional therapies; persistent, symptomatic warts 
may require alternative approaches to treatment. 
Acitretin is a promising therapeutic option for 
symptomatic viral warts recalcitrant to other 
conventional treatment modalities among certain 
patient populations.
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Supplement
Table 1: Previously reported successful treatment of warts with acitretin.
2011 Proietti et al
-Acitretin in common warts over the dorsal hands and periungually.
-Acitretin used for 12 weeks with complete resolution by 8 weeks. 
2011 Kalidayan et al
-Complete resolution of scalp warts with acitretin 0.5mg/kg/once daily and cryotherapy.
-Response achieved after 4 weeks.
-Acitretin continued for 2 additional months. 
2011 El-Khayat et al -Acitretin resulting in complete clearance of periungual warts which did not respond after 10 years of other treatments.
2008 Krupa shankar et al
-Warts on face, palms and lower limbs responding to acitretin 0.5mg/kg/day,
-No recurrence 6 months after treatment. 
2006 Choi at al -Acitretin 1 mg/kg/day with regression of recalcitrant warts on hands in 1 month, con-tinued treatment for 2 additional months,
